Detailed Result for NCT02298777
NCT ID: | NCT02298777 |
---|---|
NLM Download Date Description: | N/A |
Study First Submitted Date: | 2014-11-06 |
Last Update Submitted Date: | 2022-07-07 |
Last Update Submitted Date: | 2022-07-07 |
Result First Submitted Date: | N/A |
Disposition First Submitted Date: | N/A |
Start Month Year: | December 2014 |
Start Date: | 2014-12-31 |
Start Date Type: | Actual |
Verification Month Year: | July 2022 |
Verification Date: | 2022-07-31 |
Completion Month Year: | July 2026 |
Completion Date: | 2026-07-31 |
Completion Date Type: | Anticipated |
Primary Completion Month Year: | December 2025 |
Primary Completion Date: | 2025-12-31 |
Primary Completion Date Type: | Anticipated |
Study first Submitted QC Date: | 2014-11-19 |
Study first posted Date: | 2014-11-24 |
Result first Submitted QC Date: | N/A |
Result First Posted Date: | N/A |
Disposition First Submitted QC Date: | N/A |
Disposition First Posted Date: | N/A |
Last Updated Submitted QC Date: | 2022-07-07 |
Last Updated Posted Date: | 2022-07-08 |
Target Duration: | N/A |
Study Type: | Observational |
Acronym: | SCLEROMICS |
Baseline Population: | N/A |
Brief Title: | Metabolomic Analysis of Systemic Sclerosis |
Official Title: | Metabolomic Analysis of Systemic Sclerosis |
Overall Status: | Recruiting |
Last Known Status: | N/A |
Phase: | N/A |
Enrollment: | 140 |
Enrollment Type: | Anticipated |
Source: | University Hospital, Strasbourg, France |
Limitation and Caveats: | N/A |
Number of Arms: | N/A |
Number of Groups: | 5 |
Why Stopped: | N/A |
Has Expanded Access: | N/A |
Expanded Access Type Individual: | N/A |
Expanded Access Type Intermediate: | N/A |
Expanded Access Type Treatment: | N/A |
Has DMC: | N/A |
Is it FDA Regulated Drug: | N/A |
Is it FDA Regulated Device: | N/A |
Is it Unapproved Device: | N/A |
Is PPSD: | N/A |
Is US Export: | N/A |
Is Biospec Retention: | N/A |
Biospec Description: | N/A |
Plan to Share IPD: | N/A |
Plan to Share IPD Description: | N/A |
IPD Time Frame: | N/A |
IPD Access Criteria: | N/A |
IPD URL: | N/A |